23-Jun-2020

Dr James Garner discusses paxalisib development with the Australian Shareholders Association

Our CEO, Dr James Garner sat down with the Australian Shareholders Association to discuss the development of our lead candidate, paxalisib, for glioblastoma.

08-Jun-2020

World Brain Tumour Day: Kazia is urging awareness of the signs and symptoms of brain tumours

On World Brain Tumour Day (June 8), Kazia is calling for greater awareness of the signs and symptoms of brain tumours, as they can often be malignant and therefore, a potentially deadly condition.